Effects of PDE4 inhibitors on lipopolysaccharide-induced priming of superoxide anion production from human mononuclear cells

Mediators of Inflammation

Volumn 10, Issue 3, 2001, Pages 117-123

  Germain, Noëlla ^a   Corbe, Marianne ^a   Belleguic, Chantal ^a,b   Boichot, Elisabeth ^a   Lagente, Vincent ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Cyclic AMp Interleukin 10; Lipopolysaccharide; Mononuclear cells; Phosphodiesterase inhibitors; TNF

Indexed keywords

BUCLADESINE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; SUPEROXIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CYTOKINE RELEASE; DRUG MECHANISM; HUMAN; HUMAN CELL; INFLAMMATION; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0034897044     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350123856     Document Type: Article

References (26)

1. Multiple cyclic nucleotides phosphodiesterases
2. Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD)
3. Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors
4. Involvement of cyclic AMP in the effects of phosphodiesterase IV inhibitors on arachidonate release from mononuclear cells
5. Phosphodiesterase 4 inhibitors and db-cAMP inhibit TNF-α release from human mononuclear cells. Effects of cAMP and cGMP-dependent protein kinase inhibitors
6. Interactions between cAMP and cGMP dependent protein kinase inhibitors and phosphodiesterase IV inhibitors on arachidonate release from human monocytes
7. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages
8. Anti-inflammatory activities of cAMP-elevating agents: Enhancement of IL-10 synthesis and concurrent suppression of TNF production
9. A new technique for enhancing luminol luminescent detection of free radicals and reactive oxygen species
10. Bacterial endotoxins and host immune responses
11. Priming of eosinophil recruitment in vivo by LPS pretreatment
12. Priming of human peripheral blood mononuclear cells with lipopolysaccharides for enhanced arachidonic acid release and leukotriene synthesis
13. Activation of neutrophils by cachectin/tumor necrosis factor: Priming of N-formyl-methionyl-leucyl-phenylalanine-induced oxidative responsiveness via receptor mobilization without degranulation
14. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly
15. Phosphodiesterase (PDE)4 inhibitors: Anti-inflammatory drugs of the future?
16. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhihitors
17. Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation
18. The ability of phosphodiesterase IV inhihitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity
19. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst
20. The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity
21. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages
22. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: Comparison with rolipram
23. Anti-inflammatory activities of a new series of selective phosphodiesterase 4 inhibitors derived from 9-henzyladenine
24. The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity
25. Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes
26. Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung